These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 32785140)
1. Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract. Droździk M; Oswald S; Droździk A Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785140 [TBL] [Abstract][Full Text] [Related]
2. Impact of kidney dysfunction on hepatic and intestinal drug transporters. Droździk M; Oswald S; Droździk A Biomed Pharmacother; 2021 Nov; 143():112125. PubMed ID: 34474348 [TBL] [Abstract][Full Text] [Related]
3. Intestinal drug transporters in pathological states: an overview. Drozdzik M; Czekawy I; Oswald S; Drozdzik A Pharmacol Rep; 2020 Oct; 72(5):1173-1194. PubMed ID: 32715435 [TBL] [Abstract][Full Text] [Related]
4. Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication. Momper JD; Nigam SK Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):561-570. PubMed ID: 29746174 [TBL] [Abstract][Full Text] [Related]
5. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters. Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329 [TBL] [Abstract][Full Text] [Related]
6. Abcc6 deficiency in mice leads to altered ABC transporter gene expression in metabolic active tissues. Ibold B; Faust I; Tiemann J; Gorgels TGMF; Bergen AAB; Knabbe C; Hendig D Lipids Health Dis; 2019 Jan; 18(1):2. PubMed ID: 30611276 [TBL] [Abstract][Full Text] [Related]
7. Renal and non-renal response of ABC and SLC transporters in chronic kidney disease. Torres AM; Dnyanmote AV; Granados JC; Nigam SK Expert Opin Drug Metab Toxicol; 2021 May; 17(5):515-542. PubMed ID: 33749483 [TBL] [Abstract][Full Text] [Related]
8. Systematic Investigation of the Effects of Long-Term Administration of a High-Fat Diet on Drug Transporters in the Mouse Liver, Kidney and Intestine. Lu X; Dong Y; Jian Z; Li Q; Gong L; Tang L; Zhou X; Liu M Curr Drug Metab; 2019; 20(9):742-755. PubMed ID: 31475894 [TBL] [Abstract][Full Text] [Related]
9. A Network of SLC and ABC Transporter and DME Genes Involved in Remote Sensing and Signaling in the Gut-Liver-Kidney Axis. Rosenthal SB; Bush KT; Nigam SK Sci Rep; 2019 Aug; 9(1):11879. PubMed ID: 31417100 [TBL] [Abstract][Full Text] [Related]
10. Overview: Role of Drug Transporters in Drug Disposition and Its Clinical Significance. Liu X Adv Exp Med Biol; 2019; 1141():1-12. PubMed ID: 31571163 [TBL] [Abstract][Full Text] [Related]
11. Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression. Mayati A; Moreau A; Le Vée M; Stieger B; Denizot C; Parmentier Y; Fardel O Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375174 [TBL] [Abstract][Full Text] [Related]
13. The Structure and Mechanism of Drug Transporters. Roberts AG Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696 [TBL] [Abstract][Full Text] [Related]
14. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox. Özvegy-Laczka C; Ungvári O; Bakos É Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706 [TBL] [Abstract][Full Text] [Related]
15. The reference liver - ABC and SLC drug transporters in healthy donor and metastatic livers. Kurzawski M; Szeląg-Pieniek S; Łapczuk-Romańska J; Wrzesiński M; Sieńko J; Oswald S; Droździk M Pharmacol Rep; 2019 Aug; 71(4):738-745. PubMed ID: 31207436 [TBL] [Abstract][Full Text] [Related]
16. Use of imaging to assess the activity of hepatic transporters. Hernández Lozano I; Langer O Expert Opin Drug Metab Toxicol; 2020 Feb; 16(2):149-164. PubMed ID: 31951754 [No Abstract] [Full Text] [Related]
17. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233 [TBL] [Abstract][Full Text] [Related]
18. Xenobiotic Transporters in the Kidney: Function and Role in Toxicity. Shen H; Scialis RJ; Lehman-McKeeman L Semin Nephrol; 2019 Mar; 39(2):159-175. PubMed ID: 30827339 [TBL] [Abstract][Full Text] [Related]
19. Circadian regulation of transporter expression and implications for drug disposition. Pácha J; Balounová K; Soták M Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):425-439. PubMed ID: 33353445 [No Abstract] [Full Text] [Related]
20. Drug Transporter Function--Implications in CKD. Schwenk MH; Pai AB Adv Chronic Kidney Dis; 2016 Mar; 23(2):76-81. PubMed ID: 26979146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]